Tri Locum Partners LP Tarsus Pharmaceuticals, Inc. Transaction History
Tri Locum Partners LP
- $278 Million
- Q2 2025
A detailed history of Tri Locum Partners LP transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Tri Locum Partners LP holds 177,656 shares of TARS stock, worth $10.7 Million. This represents 2.59% of its overall portfolio holdings.
Number of Shares
177,656Holding current value
$10.7 Million% of portfolio
2.59%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
215Shares Held
46.3MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$197 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$188 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$180 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$149 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$148 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.61B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...